The Premenstrual Syndrome

Summary Treatment of the premenstrual syndrome is complicated by many factors, but principally by its unknown aetiology. In addition, diagnosis, definition and symptom evaluation methods are unclear. The multitudinous studies of treatment regimens have been largely inconclusive; this is partly due to difficulties in numerically evaluating the symptoms, but more to the lack of appreciation of the marked placebo effect which has been estimated as being up to 50%. The majority of studies have been open studies, and therefore interpretation of the results have been almost impossible. The end result is that great claims have been made for a large number of therapeutic agents on ill-founded evidence. Some of the drugs used in the treatment of the premenstrual syndrome, however, have been better evaluated than others, although even with those studied more extensively results have often been variable. Thus, hormonal agents such as progestagens and oral contraceptives, diuretics, pyridoxine, bromocriptine and danazol have been effective in some studies but not universally so. The latter 2 agents seem to be effective in relieving breast symptoms, but have only a limited effect on other symptoms. It is therefore important to realise that one drug does not cure all patients or all symptoms, although it is often claimed that this is the case. It has been suggested that more than 40% of women suffer from premenstrual syndrome. Greater awareness of the problem, both by patients and doctors, necessitates a more rational approach to therapy. Similar content being viewed by others References Adams, P.W.; Rose, D.P.; Folkard, J.; Wynn, V.; Seed, M. and Strong, R.: Effect of pyridoxine hydrochloride (vitamin B6) upon depression associated with oral contraception. Lancet 1: 897 (1973). Altmann, M.; Knowles, E. and Bull, H.D.: A psychosomatic study of the sex cycle in women. Psychosomatic Medicine 3: 199 (1941). Andersch, B.; Hahn, L.; Wendestam, C. and Abrahamsson, L.: Treatment of premenstrual syndrome with bromocriptine. Acta Endocrinologica 88 (Suppl. 216): 165 (1978). Andersch, B.; Abrahamsson, L.; Wendestam, C.; Ohman, R. and Hahn, L.: Hormone profile in premenstrual tension: Effects of bromocriptine and diuretics. Clinical Endocrinology 11: 657 (1979). Andersen, A.N. and Larsen, J.F.: Bromocriptine in the treatment of the premenstrual syndrome. Drugs 17: 383–388 (1979). Andersen, A.N.; Larsen, J.F.; Steenstrup, O.R.; Svendstrup, B. and Nielsen, J.: Effect of bromocriptine on the premenstrual syndrome. A double-blind clinical trial. British Journal of Obstetrics and Gynaecology 84: 370 (1977). Appleby, B.P.: A study of premenstrual tension in general practice. British Medical Journal 1: 391 (1960). Argonz, J. and Abinzano, C: Premenstrual tension treated with Vitamin A. Journal of Clinical Endocrinology 10: 1579 (1950). Backstrom, T. and Mattsson, B.: Correlation of symptoms in premenstrual tension to oestrogen and progesterone concentrations in blood plasma. Neuropsychobiology 1: 80 (1975). Backstrom, C.T.; Boyle, H. and Baird, D.T.: Persistence of symptoms of premenstrual tension in hysterectomized women. British Journal of Obstetrics and Gynaecology 88: 530 (1981). Baden, W.F. and Lizcano, H.R.: Evaluation of a new diuretic drug (quinethazone) in the premenstrual tension syndrome. Journal of New Drugs 3: 167 (1963). Benedek-Jaszmann, L.J. and Hearn-Sturtevant, M.D.: Premenstrual tension and functional infertility. Aetiology and treatment. Lancet 1: 1095 (1976). Benedek-Jaszmann, L.J.; Lequin, R.N. and Sternthal, V.: Treatment of the premenstrual syndrome with bromocriptine. Acta Endocrinologia 193 (Suppl.): 29 (1975). Biskind, M.S.: Nutritional deficiency in the aetiology of menor-rhagia, cystic mastitis and premenstrual tension; treatment with Vitamin B complex. Journal of Clinical Endocrinology 3: 227 (1943). Block, E.: The use of Vitamin A in premenstrual tension. Acta Obstetricia et Gynecologica Scandinavica 39: 586 (1960). Bruce, J. and Russell, G.F.M.: Premenstrual tension. A study of weight changes and balances of water, sodium and potassium. Lancet 2: 267 (1962). Brush, M.G.: Efamol in the treatment of premenstrual syndrome. Proceedings of 1 st Symposium on the Clinical Uses of Efamol and Essential Fatty Acids, London (1981). Carstairs, M.W. and Talbot, D.J.: A placebo controlled trial of Tenavoid in the management of premenstrual syndrome. British Journal of Clinical Practice. In press (1982). Chesley, L.C. and Hellman, L.M.: Variation in body weight and salivary sodium in the menstrual cycle. American Journal of Obstetrics and Gynecology 74: 582 (1957). Coppen, A.J.; Milne, H.B.; Outram, D.H. and Weber, J.C.P.: Dytide, norethisterone and placebo in the premenstrual syndrome. Clinical Trials Journal 6: 33 (1969). Cullberg, J.: Mood changes and menstrual symptoms with different gestagen/oestrogen combinations. Acta Psychiatrica Scandinavica 236 (Suppl.): 1 (1972). Dalton, K.: Comparative trial of new oral progestagenic compounds in treatment of premenstrual syndrome. British Medical Journal 2: 1307 (1959). Dalton, K.: The Premenstrual Syndrome and Progesterone Therapy (Heinemann Year Book Medical Publishers, London 1977). Day, J.B.: Clinical trials in the premenstrual syndrome. Current Medical Research and Opinion 6 (Suppl. 5): 40 (1979a). Day, J.B.: Danazol and the premenstrual syndrome. Postgraduate Medical Journal 55 (Suppl. 5): 87 (1979b). Fortin, J.N.; Wittkower, E.D. and Kalz, F.: A psychosomatic approach to the premenstrual tension syndrome. A preliminary report. Canadian Medical Association Journal 79: 978 (1958). Frank, R.T.: The hormonal causes of premenstrual tension. Archives of Neurological Psychiatry 26: 1053 (1931). Friesen, H.G.; Hwang, P.; Guyda, H.; Tolis, G.; Tyson, J. and Myers, R.: Radioimmunoassay for human prolactin; in Boynes and Griffiths (Eds) Prolactin and Carcinogenesis, p.64 (Alpha Omega Alpha Publishing, Cardiff 1972). Ghose, K. and Coppen, A.: Bromocriptine and premenstrual syndrome: Controlled study. British Medical Journal 1: 147 (1977). Graham, J.J.; Harding, P.E.; Wise, P.H. and Berriman, H.: Prolactin suppression in the treatment of premenstrual syndrome. Medical Journal of Australia (Suppl.) 2: 18 (1978). Greenblatt, R.B.: Fibrocystic disease of the breast. British Journal of Sexual Medicine 8: 13 (1981). Greenblatt, B. and Ben-Nun, I.: Danazol in the treatment of mammary dysplasia. Drugs 19: 349–355 (1980). Greene, R. and Dalton, K.: The premenstrual syndrome. British Medical Journal 1: 1007 (1953). Halbreich, U.; Assael, M.; Ben-David, M. and Bornstein, R.: Serum-prolactin in women with premenstrual syndrome. Lancet 2: 654 (1976). Harrison, P. and Letchworth, A.T.: Bromocriptine in the treatment of the premenstrual syndrome. Proceedings from a symposium held at the Royal College of Physicians, London, p.103 (14th May, 1976). Haspels, A.A.: A double-blind, placebo-controlled, multicentre study of the efficacy of dydrogesterone (Duphaston); in Proceedings of a Workshop held during the Sixth International Congress of Psychosomatic Obstetrics and Gynaecology, Berlin, p.81 (September, 1980). Hoffman, J.J.: A double blind crossover clinical trial of an OTC diuretic in the treatment of premenstrual tension and weight gain. Current Therapeutic Research 26: 575 (1979). Horrobin, D.F.; Lloyd, I.J. and Lipton, A.: Actions of prolactin on human renal function. Lancet 2: 352 (1971). Israel, S.L.: Premenstrual tension. Journal of the American Medical Association 110: 1721 (1938). Jordheim, O.: The premenstrual syndrome. Clinical trials of treatment with a progestogen combined with diuretic compared with both a progestogen alone and with a placebo. Acta Obstetricia et Gynecologica Scandinavica 51: 77 (1972). Jungck, E.C.; Barfield, W.E. and Greenblatt, R.E.: Chlorothiazide and premenstrual tension. Journal of the American Medical Association 169: 112 (1959). Kerr, G.D.: The management of premenstrual syndrome. Current Medical Research and Opinion 4 (Suppl. 4): 29 (1977). Kerr, G.D.; Day, J.B.; Munday, M.R.; Brush, M.G.; Watson, M. and Taylor, R.W.: Dydrogesterone in the treatment of the premenstrual syndrome. Practitioner 224: 852 (1980). Kramer, H.: A long acting diuretic suitable for outpatient treatment of fluid retention on oedema of pregnancy and the premenstrual tension syndrome. African Medical Journal 36: 4 (1962). Kutner, S.J. and Brown, W.L.: Types of oral contraceptives, depression and premenstrual symptoms. Journal of Nervous and Mental Diseases 155: 153 (1972). MacGregor, G.A.; Roulston, J.E.; Markandu, N.D.; Jones, J.C. and de Wardener, H.E.: Is ‘idiopathic’ oedema idiopathic? Lancet 1: 397 (1979). McNeilly, A.S.; Sturdy, J.; Evans, D.G. and Chard, T.: Short term variation in blood levels of prolactin, luteinizing hormone and follicle stimulating hormone in normal men throughout the day. Journal of Endocrinology 61: 301 (1974). Mansel, R.E.; Preece, P.E. and Hughes, L.E.: A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease. British Journal of Surgery 65: 724 (1978). Mansel, R.E.; Wisbey, J.R. and Hughes, L.E.: The use of Danazol in the treatment of painful benign breast disease: Preliminary results. Postgraduate Medical Journal 55 (Suppl. 5): 51 (1979). Mattson, B. and van Schoultz, B.: A comparison between lithium, placebo and a diuretic in premenstrual tension. Acta Psychiatrica Scandinavica 255 (Suppl.): 75 (1974). Moos, R.H.: Menstrual distress questionnaire preliminary manual. Department of Psychiatry, Stanford University School of Medicine (1969). Morris, N.M. and Udry, J.R.: Contraceptive pills and the day-today feelings of well-being. American Journal of Obstetrics and Gynecology 113: 763 (1972). Munday, M.R.; Brush, M.G. and Taylor, R.W.: Correlates between progesterone, oestradiol and aldosterone levels in the premenstrual syndrome. Clinical Endocrinology 14: 1 (1981). O’Brien, P.M.S.: Endocrine changes in premenstrual syndrome. MD Thesis, University of Wales (1979). O’Brien, P.M.S.; Craven, D.; Selby, C. and Symonds, E.M.: Treatment of premenstrual syndrome by spironolactone. British Journal of Obstetrics and Gynaecology 86: 142 (1979). O’Brien, P.M.S.; Selby, C. and Symonds, E.M.: Progesterone, fluid and electrolytes in premenstrual syndrome. British Medical Journal 280: 1161 (1980). Pennington, V.M.: Meprobromate (Miltown) in premenstrual tension. Journal of the American Medical Association 164: 638 (1957). Piton, R.: Evaluation of dydrogesterone in the treatment of the premenstrual syndrome. Ars Medici 8: 1785 (1979). Preece, P.E. and Mansel, R.E.: Management of breast pain using Efamol. Proceedings of 1st Symposium on the Clinical Uses of Efamol and Essential Fatty Acids, London (1981). Rees, L.: Psychosomatic aspects of the premenstrual tension syndrome. Journal of Mental Science 99: 62 (1953). Reeves, B.D.; Garvin, J.E. and McElin, T.W.: Premenstrual tension: Symptoms and weight changes related to potassium therapy. American Journal of Obstetrics and Gynecology 109: 1036 (1971). Reid, R.L. and Yen, S.S.C.: Premenstrual syndrome. American Journal of Obstetrics and Gynecology 139: 85 (1981). Robinson, K.; Huntington, K. and Wallace, M.G.: Treatment of the premenstrual syndrome. British Journal of Obstetrics and Gynaecology 84: 784 (1977). Romanini, C.; Liverani, A.; Arduini, D.; Lafuenti, G. and Manfredi, L.: Nuove osservazioni sul trattamento di sindromi premestruali associate a dismenorrea con 6-deidro-retro-progesterone. Annali Di Ostetricia, Ginecologia, Medicina Perinatale 100: 250 (1979). Royal College of General Practitioners: Oral contraceptives and health. Pitman Medical, London (1974). Sampson, G.A.: Premenstrual syndrome: A double-blind controlled trial of progesterone and placebo. British Journal of Psychiatry 130: 265 (1979). Simkin, B. and Acre, R.: Prolactin activity in blood during the normal human menstrual cycle. Proceedings of the Society of Biological Experiments in Medicine 113: 485 (1963). Singer, K.; Cheng, R. and Schou, M.: A controlled evaluation of lithium in the premenstrual syndrome. British Journal of Psychiatry 124: 50 (1974). Sletten, I.W. and Gershon, S.: The premenstrual syndrome: A discussion of its pathophysiology and treatment with lithium ion. Comprehensive Psychiatry 7: 197 (1966). Smith, S.L.: Mood and the menstrual cycle; in Sachar (Ed.) Topics in Psychoendocrinology pp. 19–58 (Grune and Stratton, New York 1975). Stielglitz, M.D. and Kimble, S.T.: Premenstrual intoxication. American Journal of Medical Science 218: 616 (1949). Stokes, J. and Mendels, J.: Pyridoxine and premenstrual tension. Lancet 1: 1177 (1972). Strecker, J.: Treatment of premenstrual syndrome with retroprogesterone (duphaston). Fortschritte der Medizin (Leipzig) 98: 145 (1980). Sweeney, J.S.: Menstrual oedema. Journal of the American Medical Association 103: 234 (1934). Swyer, G.I.M.: Treatment of premenstrual tension syndrome: Value of ethisterone, mephenesin and a placebo compared. British Medical Journal 1: 1410 (1955). Taylor, R.W.: The treatment of premenstrual syndrome with dydrogesterone (‘Duphaston’). Current Medical Research and Opinion 4 (Suppl. 4): 35 (1977). Taylor, R.W. and James, C.E.: The clinician’s view of patients with premenstrual syndrome. Current Medical Research and Opinion 6 (Suppl. 5): 46 (1979). Vekemans, M.; Delvoye, P.; L’Hermite, M. and Robyn, C.: Serum prolactin levels during the menstrual cycle. Journal of Clinical Endocrinology and Metabolism 44: 989 (1977). Werch, A. and Kane, R.E.: Treatment of premenstrual tension with metolazone: A double-blind evaluation of a new diuretic. Current Therapeutic Research 19: 565 (1976). Wood, C. and Jakubowicz, D.: The treatment of premenstrual symptoms with mefenamic acid. British Journal of Obstetrics and Gynaecology 87: 627 (1980). Author information Authors and Affiliations Rights and permissions About this article Cite this article O’Brien, P.M.S. The Premenstrual Syndrome. Drugs 24, 140–151 (1982). https://doi.org/10.2165/00003495-198224020-00004 Published: Issue date: DOI: https://doi.org/10.2165/00003495-198224020-00004